Speaker Bio | Click to return to meeting home page
Rodolphe Barrangou Ph.D. is the T. R. Klaenhammer Distinguished Professor in Probiotics Research at North Carolina State University. Barrangou is focusing on the characterization of CRISPR-Cas systems, and their applications in bacteria. Rodolphe spent 9 years in R&D and M&A at DuPont. For his CRISPR work, Rodolphe received several international awards, and has been elected into the National Academy of Sciences and the National Academy of Engineering. Dr. Barrangou is also the former Chairman of the Board of Caribou Biosciences, a co-founder of Intellia Therapeutics, Locus Biosciences, TreeCo and CRISPR biotechnologies, and the Editor in Chief of the CRISPR Journal.